Zomato CEO Defends Temple Wearable Device Against Fraud Claims

Zomato founder and CEO Deepinder Goyal has responded to criticism of his Temple wearable device, which tracks health metrics, following public allegations by Dr Cyriac Abby Philips, a leading liver specialist. The hepatologist had raised concerns about the device's claims and its credibility in the medical community.

Goyal defended the product by highlighting substantial investments from major venture capital firms backing the venture, signalling confidence from institutional investors in the technology. He also pointed to the availability of a comprehensive return policy for consumers, positioning it as a safeguard against customer dissatisfaction.

The Temple device maker further committed to pursuing additional scientific validation of the product's efficacy, acknowledging the importance of clinical evidence in gaining medical community acceptance. This planned validation appears to be an attempt to address concerns raised by health professionals about the device's substantive claims.

The exchange underscores growing scrutiny of consumer health technology products in India, where wearables and health-tracking devices have proliferated rapidly. The debate highlights the tension between innovation and regulatory oversight in the emerging health-tech sector, with medical professionals calling for rigorous scientific backing before widespread adoption of such devices.